Wednesday, 20 February 2013

Colombia Pharmaceuticals and Healthcare Market Report Q1 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Colombia Pharmaceuticals and Healthcare Report Q1 2013
Feb 6th 2013, 00:00

BMI View: Improvements in Colombia''s pharmaceutical regulation system will expand local patients''access to medicines. However, it will also put pricing pressures on drugmakers, and promote the use ofgeneric versions, which will undermine the growth of patented drug market. Nevertheless, BMI expectsmore foreign pharmaceutical companies to invest in Colombia, capitalising on the country''s strong longtermgrowth prospects.Headline Expenditure Projections?? Pharmaceuticals: COP7,076bn (US$3.83bn) in 2011 to COP7,612bn (US$4.23bn) in 2012;+7.6% in local currency terms and +10.4% in US dollar terms. Forecast broadly in line withQ412.?? Healthcare: COP29,953...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment